ProCE Banner Activity

Antiretroviral Pregnancy Registry Analysis of Outcomes of Maternal DTG Use in Pregnancy

Slideset Download
Conference Coverage
Analysis of international registry data through January 2021 shows that prevalence of birth defects with prenatal DTG is comparable with that seen in the general population.

Released: October 05, 2021

Expiration: October 04, 2022

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Ferring Pharmaceuticals, Inc.

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp

ViiV Healthcare